Biosimilars Interchangeability

Summary

The ACMA takes a detailed look into the world of biologics and Dr. Ellen M. Field, MD, a privately practicing rheumatologist in Lehigh Valley, PA, talks about the FDA 2017 guidance that advised ... along with this simple, animated white board video to learn about Biologics can provide valuable options for patients, helping them find the right treatment. There are three kinds of biologics: ... Biologics are the fastest-growing therapeutic category in the U..S, but they are expensive. Learn more about how Eva Temkin from CDER's Office of New Drugs shares an overview of FDA's perspective on the regulatory considerations ... ASBM's inaugural Chair, Richard Dolinar MD; and his successors Immediate Past Chair Harry Gewanter MD MACR; and ASBM's ... In this CME Outfitters live Q & A session, expert faculty will go in-depth answering your questions while offering evidence, ... Professor Angela Thomas, Royal Hospital for Sick Children, Edinburgh, UK, presented at Pharmacology 2016, the British ... The patents on many well-known biological drugs will soon expire, giving drug developers the opportunity to make generic ...